Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -2.31% | 324.21 | 0.0% | $4670.09m | |
| BNTX | BioNTech SE | -1.06% | 247.68 | 0.0% | $730.32m | |
| NVAX | Novavax, Inc. | -4.59% | 161.95 | 79.4% | $715.24m | |
| AMGN | Amgen, Inc. | 0.51% | 207.84 | 1.4% | $575.65m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -7.57% | 6.47 | 0.7% | $452.28m | |
| GILD | Gilead Sciences, Inc. | -0.76% | 67.63 | 1.0% | $426.45m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.43% | 553.24 | 2.7% | $408.99m | |
| ILMN | Illumina, Inc. | 0.45% | 409.93 | 3.3% | $392.87m | |
| CCXI | ChemoCentryx, Inc. | -7.04% | 34.47 | 2.9% | $387.64m | |
| XLRN | Acceleron Pharma, Inc. | 0.50% | 172.94 | 5.3% | $345.45m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.07% | 181.77 | 1.9% | $259.59m | |
| BIIB | Biogen, Inc. | -1.43% | 281.19 | 1.7% | $243.39m | |
| OCGN | Ocugen, Inc. | -13.83% | 8.66 | 0.0% | $178.37m | |
| XENE | Xenon Pharmaceuticals, Inc. | 2.12% | 33.66 | 0.4% | $178.19m | |
| JSPR | Jasper Therapeutics, Inc. | 31.57% | 16.42 | 0.0% | $158.53m |
Company Profile
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.